Daypro and Bone fragmentation - a phase IV clinical study of FDA data

Summary:

Bone fragmentation is reported as a side effect among people who take Daypro (oxaprozin), especially for people who are female, 50-59 old, also take Decadron, and have Multiple myeloma.

The phase IV clinical study analyzes which people have Bone fragmentation when taking Daypro. It is created by eHealthMe based on reports of 2,818 people who have side effects when taking Daypro from the FDA, and is updated regularly.

What is Daypro?

Daypro has active ingredients of oxaprozin. It is often used in osteoarthritis. eHealthMe is studying from 2,883 Daypro users. Check the latest studies of Daypro.

What is Bone fragmentation?

Bone fragmentation is found to be associated with 362 drugs and 245 conditions by eHealthMe. Check the latest studies of Bone fragmentation.

On Jul, 14, 2026

2,818 people reported to have side effects when taking Daypro.
Among them, 11 people (0.39%) have Bone fragmentation.

Among these 11 people:

What is the gender of people who have Bone fragmentation when taking Daypro? *

female: 100 %
male: 0.0 %

What is the age of people who have Bone fragmentation when taking Daypro? *

What are other drugs people take besides Daypro? *

What are other side effects people have besides Bone fragmentation? *

Hypertensive Heart Disease: 11 people, 100.00%
Pathogen Resistance: 11 people, 100.00%
Pain In Extremity: 11 people, 100.00%
Osteopenia (a condition where bone mineral density is lower than normal): 11 people, 100.00%
Osteomyelitis (infection of bone): 11 people, 100.00%
Myocardial Ischaemia (the blood flow through one or more of the blood vessels that lead to heart (coronary arteries) is decreased): 11 people, 100.00%
Multiple Myeloma (cancer of the plasma cells): 11 people, 100.00%
Hypermetropia (abnormal condition in which vision for distant objects is better than for near objects): 11 people, 100.00%
Gingival Infection (gum infection): 11 people, 100.00%
Gingival Erythema (redness of gums): 11 people, 100.00%

What are the existing conditions these people have? *

Multiple Myeloma (cancer of the plasma cells): 11 people, 100.00%

* Approximation only. Some reports may have incomplete information.

Do you take Daypro and have Bone fragmentation?

- Check whether Bone fragmentation is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Daypro:

Daypro (2,883 reports)

Browse all side effects of Daypro:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Bone fragmentation:

Bone fragmentation (362 drugs)

Browse all the conditions that are associated with Bone fragmentation:

Bone fragmentation (245 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on oxaprozin (the active ingredients of Daypro) and Daypro (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.